AIM discusses draft HTA regulation with Commissioner Andriukaitis
27 April – AIM met today with European Commissioner for Health, Mr Vytenis Andriukaitis. We discussed the Commission’s proposal for a regulation on health technology assessment (HTA). We mentioned our concerns about the obligation for national authorities to use the joint clinical assessment reports. Some AIM members are reluctant to accept such an obligation as long as there are uncertainties about the timing of those assessments, the methodology that will be used, the transparency of data used, etc etc. AIM members would also be helped with more clarity about the possibilities to do additional assessments. The Commissioner indicated that he will, together with Council and Parliament work on further clarifying the proposal on these points. He also agreed that, to keep the assessments objective and independent, the financing of assessments, but also joint scientific consultations, should not include direct contributions from the pharmaceutical industry.
On the picture, from left to right; Menno Aarnout (Executive Director AIM), Mr Vytenis Andriukaitis (European Commissioner for Health and Food Safety), Mrs Jocelyn Stokx (pharmacist at the Belgian Christian Mutuality) and Hans Seyfried (pharmaceuticals expert at the Social Security Institution for Farmers (SVB) in Austria.